← Leaderboards
Beatriz Grinsztejn
Fundacao Oswaldo Cruz
$40,662,171
Attributed
$43,685,912
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$43,685,912 · 6
By mechanism
UM1$23,681,534 · 1
U01$13,956,895 · 1
R01$4,567,271 · 2
R13$940,000 · 1
UG3$540,212 · 1
Top collaborators
- Jessica L Castilho7 shared
- William Mcfarland4 shared
- Erin Catherine Meek2 shared
- Chris Beyrer1 shared
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelBrazilParticipantCaringPersonsCollaborationsEpidemicAffectFoundationsSiteInsightInfectionUnited States National Institutes Of HealthAids PreventionComorbidityBaseTuberculosisClinical TrialsHiv InfectionsAids Clinical Trial GroupClinical Research SiteCommunitiesPreventionLeadership
Grant awards (32)
IAS 2025. the 13th IAS Conference on HIV Science, Kigali, Rwanda, 14-17 July 2025$940,000
R13 · FY2025 · AI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.$869,573
UM1 · FY2025 · AI · contact PI
Longitudinal Study of HIV and Aging in Brazil$635,549
R01 · FY2025 · AG
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.$1,303,154
UM1 · FY2024 · AI · contact PI
Longitudinal Study of HIV and Aging in Brazil$654,308
R01 · FY2024 · AG
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.$1,528,344
UM1 · FY2023 · AI · contact PI
Longitudinal Study of HIV and Aging in Brazil$694,692
R01 · FY2023 · AG
Longitudinal Study of HIV and Aging in Brazil$435,598
R01 · FY2023 · AG
San Francisco-Rio de Janeiro collaborative research on HIV prevalence, risk, and biomedical prevention interventions among young men who have sex with men$110,454
R01 · FY2023 · AI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.$1,747,343
UM1 · FY2022 · AI · contact PI
Longitudinal Study of HIV and Aging in Brazil$648,264
R01 · FY2022 · AG
Longitudinal Study of HIV and Aging in Brazil$371,202
R01 · FY2022 · AG
San Francisco-Rio de Janeiro collaborative research on HIV prevalence, risk, and biomedical prevention interventions among young men who have sex with men$110,454
R01 · FY2022 · AI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.$2,790,912
UM1 · FY2021 · AI · contact PI
Longitudinal Study of HIV and Aging in Brazil$682,853
R01 · FY2021 · AG
San Francisco-Rio de Janeiro collaborative research on HIV prevalence, risk, and biomedical prevention interventions among young men who have sex with men$110,897
R01 · FY2021 · AI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit$2,006,794
UM1 · FY2020 · AI · contact PI
San Francisco-Rio de Janeiro collaborative research on HIV prevalence, risk, and biomedical prevention interventions among young men who have sex with men$113,000
R01 · FY2020 · AI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit$2,828,231
UM1 · FY2019 · AI · contact PI
The BeT intervention to reduce HIV prevention and care disparities among young transwomen in Rio De Janeiro$296,513
UG3 · FY2019 · HD
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit$773,601
UM1 · FY2018 · AI · contact PI
The BeT intervention to reduce HIV prevention and care disparities among young transwomen in Rio De Janeiro$243,699
UG3 · FY2018 · HD
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit$1,397,306
UM1 · FY2017 · AI · contact PI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit$1,104,340
UM1 · FY2016 · AI · contact PI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit$1
UM1 · FY2015 · AI · contact PI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit$1,995,627
UM1 · FY2014 · AI · contact PI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)$3,247,921
UM1 · FY2013 · AI · contact PI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)$2,088,387
UM1 · FY2012 · AI · contact PI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)$2,760,701
U01 · FY2011 · AI · contact PI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)$3,443,887
U01 · FY2010 · AI · contact PI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)$4,557,836
U01 · FY2009 · AI · contact PI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)$3,194,471
U01 · FY2008 · AI · contact PI